QQQ   311.23 (+0.29%)
AAPL   160.18 (+0.57%)
MSFT   277.07 (+1.20%)
META   204.02 (+0.92%)
GOOGL   105.30 (+0.36%)
AMZN   100.58 (-0.03%)
TSLA   196.54 (-0.53%)
NVDA   270.74 (+3.34%)
NIO   9.27 (+0.00%)
BABA   84.18 (+0.57%)
AMD   99.29 (+3.50%)
T   18.58 (+0.22%)
F   11.79 (+0.60%)
MU   59.11 (+0.82%)
CGC   1.94 (-1.52%)
GE   91.54 (-0.69%)
DIS   96.50 (-0.04%)
AMC   4.55 (+3.17%)
PFE   40.40 (-0.64%)
PYPL   75.77 (-1.24%)
NFLX   301.36 (-1.45%)
QQQ   311.23 (+0.29%)
AAPL   160.18 (+0.57%)
MSFT   277.07 (+1.20%)
META   204.02 (+0.92%)
GOOGL   105.30 (+0.36%)
AMZN   100.58 (-0.03%)
TSLA   196.54 (-0.53%)
NVDA   270.74 (+3.34%)
NIO   9.27 (+0.00%)
BABA   84.18 (+0.57%)
AMD   99.29 (+3.50%)
T   18.58 (+0.22%)
F   11.79 (+0.60%)
MU   59.11 (+0.82%)
CGC   1.94 (-1.52%)
GE   91.54 (-0.69%)
DIS   96.50 (-0.04%)
AMC   4.55 (+3.17%)
PFE   40.40 (-0.64%)
PYPL   75.77 (-1.24%)
NFLX   301.36 (-1.45%)
QQQ   311.23 (+0.29%)
AAPL   160.18 (+0.57%)
MSFT   277.07 (+1.20%)
META   204.02 (+0.92%)
GOOGL   105.30 (+0.36%)
AMZN   100.58 (-0.03%)
TSLA   196.54 (-0.53%)
NVDA   270.74 (+3.34%)
NIO   9.27 (+0.00%)
BABA   84.18 (+0.57%)
AMD   99.29 (+3.50%)
T   18.58 (+0.22%)
F   11.79 (+0.60%)
MU   59.11 (+0.82%)
CGC   1.94 (-1.52%)
GE   91.54 (-0.69%)
DIS   96.50 (-0.04%)
AMC   4.55 (+3.17%)
PFE   40.40 (-0.64%)
PYPL   75.77 (-1.24%)
NFLX   301.36 (-1.45%)
QQQ   311.23 (+0.29%)
AAPL   160.18 (+0.57%)
MSFT   277.07 (+1.20%)
META   204.02 (+0.92%)
GOOGL   105.30 (+0.36%)
AMZN   100.58 (-0.03%)
TSLA   196.54 (-0.53%)
NVDA   270.74 (+3.34%)
NIO   9.27 (+0.00%)
BABA   84.18 (+0.57%)
AMD   99.29 (+3.50%)
T   18.58 (+0.22%)
F   11.79 (+0.60%)
MU   59.11 (+0.82%)
CGC   1.94 (-1.52%)
GE   91.54 (-0.69%)
DIS   96.50 (-0.04%)
AMC   4.55 (+3.17%)
PFE   40.40 (-0.64%)
PYPL   75.77 (-1.24%)
NFLX   301.36 (-1.45%)
NASDAQ:NMRD

Nemaura Medical - NMRD Stock Forecast, Price & News

$0.74
+0.03 (+4.21%)
(As of 03/22/2023 01:55 PM ET)
Add
Compare
Today's Range
$0.70
$0.74
50-Day Range
$0.71
$2.86
52-Week Range
$0.70
$4.58
Volume
32,936 shs
Average Volume
184,826 shs
Market Capitalization
$21.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.50

Nemaura Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
812.9% Upside
$6.50 Price Target
Short Interest
Healthy
0.26% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.97
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.56) to ($0.49) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.57 out of 5 stars

Medical Sector

104th out of 983 stocks

Surgical & Medical Instruments Industry

11th out of 100 stocks


NMRD stock logo

About Nemaura Medical (NASDAQ:NMRD) Stock

Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.

Receive NMRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

NMRD Stock News Headlines

This Trade Strategy Outpaces Almost Anything
Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. pixel
This Trade Strategy Outpaces Almost Anything
Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. pixel
Nemaura Medical
Nemaura Medical Inc. (NMRD)
See More Headlines
Receive NMRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

NMRD Company Calendar

Last Earnings
11/15/2021
Today
3/22/2023
Fiscal Year End
3/31/2023
Next Earnings (Estimated)
6/29/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NMRD
Fax
N/A
Employees
25
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.50
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+812.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-13,890,000.00
Pretax Margin
-3,382.37%

Debt

Sales & Book Value

Annual Sales
$500,000.00
Book Value
$0.02 per share

Miscellaneous

Free Float
14,507,000
Market Cap
$20.58 million
Optionable
Optionable
Beta
-0.02

Key Executives

  • Dewan Fazlul Hoque Chowdhury
    Chairman, President, CEO, CFO & CAO
  • Arash Ghadar
    Chief Operating Officer
  • Richard Toon
    Manager-Technical & Business Development
  • Bashir Timol
    Director & Chief Business Officer
  • Jay L. Warner
    Head-US Commercial Operations













NMRD Stock - Frequently Asked Questions

Should I buy or sell Nemaura Medical stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nemaura Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" NMRD shares.
View NMRD analyst ratings
or view top-rated stocks.

What is Nemaura Medical's stock price forecast for 2023?

2 Wall Street analysts have issued 12-month target prices for Nemaura Medical's stock. Their NMRD share price forecasts range from $6.00 to $7.00. On average, they predict the company's share price to reach $6.50 in the next year. This suggests a possible upside of 812.9% from the stock's current price.
View analysts price targets for NMRD
or view top-rated stocks among Wall Street analysts.

How have NMRD shares performed in 2023?

Nemaura Medical's stock was trading at $1.7171 at the beginning of the year. Since then, NMRD shares have decreased by 58.5% and is now trading at $0.7120.
View the best growth stocks for 2023 here
.

Are investors shorting Nemaura Medical?

Nemaura Medical saw a decrease in short interest in February. As of February 28th, there was short interest totaling 37,700 shares, a decrease of 71.7% from the February 13th total of 133,300 shares. Based on an average trading volume of 153,300 shares, the short-interest ratio is currently 0.2 days. Approximately 0.3% of the shares of the company are short sold.
View Nemaura Medical's Short Interest
.

When is Nemaura Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 29th 2023.
View our NMRD earnings forecast
.

How were Nemaura Medical's earnings last quarter?

Nemaura Medical Inc. (NASDAQ:NMRD) released its earnings results on Monday, November, 15th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by $0.04.

What is Nemaura Medical's stock symbol?

Nemaura Medical trades on the NASDAQ under the ticker symbol "NMRD."

Who are Nemaura Medical's major shareholders?

Nemaura Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Nemaura Medical?

Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nemaura Medical's stock price today?

One share of NMRD stock can currently be purchased for approximately $0.71.

How much money does Nemaura Medical make?

Nemaura Medical (NASDAQ:NMRD) has a market capitalization of $20.58 million and generates $500,000.00 in revenue each year. The company earns $-13,890,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis.

How can I contact Nemaura Medical?

Nemaura Medical's mailing address is 57 WEST 57TH STREET, MANHATTAN NY, 10019. The official website for the company is nemauramedical.com. The company can be reached via phone at (646) 416-8000 or via email at brets@coreir.com.

This page (NASDAQ:NMRD) was last updated on 3/22/2023 by MarketBeat.com Staff